GEVA

SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA

Delisted

GEVA was delisted on the 22nd of June, 2015.

115 hedge funds and large institutions have $3.53B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 21 closing their positions.

Holders
115
Holders Change
Holders Change %
0%
% of All Funds
3.31%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
22
Increased
46
Reduced
37
Closed
21
Calls
$31.3M
Puts
$63.9M
Net Calls
-$32.5M
Net Calls Change
-$7.68M
Name Market Value Shares Shares
Change
Shares
Change %
ARC
126
Absolute Return Capital
Massachusetts
-12,875 Closed
SG Americas Securities
127
SG Americas Securities
New York
-9,662 Closed
HH
128
HWG Holdings
Texas
-8,219 Closed
PCM
129
Prelude Capital Management
New York
-6,638 Closed
BACM
130
Blue Arrow Capital Management
New York
-6,000 Closed
Jane Street
131
Jane Street
New York
-4,567 Closed
HI
132
HBK Investments
Texas
-3,200 Closed
QT
133
Quantbot Technologies
New York
-200 Closed
Millennium Management
134
Millennium Management
New York
-100 Closed
TRCT
135
Tower Research Capital (TRC)
New York
-29 Closed
M&T Bank
136
M&T Bank
New York
-21 Closed
PG
137
PEAK6 Group
Illinois
HCM
138
Highbridge Capital Management
New York